Immune Response to Molecular Radiotherapy with <sup>177</sup> Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome
- DOI
- 10.1089/cbr.2024.0031
- Published
- 2024-09-01
- Container
- Cancer Biotherapy and Radiopharmaceuticals
- Publisher
- SAGE Publications
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1089/cbr.2024.0031,
title = {Immune Response to Molecular Radiotherapy with
<sup>177</sup>
Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome},
author = {Andreas Kluge and Richard P. Baum and Norman Bitterlich and Harshad R. Kulkarni and Ulrike Schorr-Neufing and Cees J.A. van Echteld},
year = {2024},
journal = {Cancer Biotherapy and Radiopharmaceuticals},
doi = {10.1089/cbr.2024.0031},
url = {https://doi.org/10.1089/cbr.2024.0031}
}RIS
TY - JOUR
TI - Immune Response to Molecular Radiotherapy with
<sup>177</sup>
Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome
AU - Andreas Kluge
AU - Richard P. Baum
AU - Norman Bitterlich
AU - Harshad R. Kulkarni
AU - Ulrike Schorr-Neufing
AU - Cees J.A. van Echteld
PY - 2024
JO - Cancer Biotherapy and Radiopharmaceuticals
DO - 10.1089/cbr.2024.0031
UR - https://doi.org/10.1089/cbr.2024.0031
ER - APA
Kluge, A., Baum, R. P., Bitterlich, N., Kulkarni, H. R., Schorr-Neufing, U., & Echteld, C. J. V. (2024). Immune Response to Molecular Radiotherapy with <sup>177</sup> Lu-DOTATOC: Predictive Value of Blood Cell Counts for Therapy Outcome. Cancer Biotherapy and Radiopharmaceuticals. https://doi.org/10.1089/cbr.2024.0031
Source records
- crossref · retrieved 2026-09-26T20:01:55.863Z